Legacy Bridge’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.06M | Hold |
2,115
| – | – | 0.33% | 90 |
|
|
2026
Q1 | $1.04M | Sell |
2,115
-37
| -2% | -$20.1K | 0.4% | 83 |
|
|
2025
Q4 | $1.25M | Hold |
2,152
| – | – | 0.51% | 70 |
|
|
2025
Q3 | $1.04M | Sell |
2,152
-34
| -2% | -$15.8K | 0.43% | 76 |
|
|
2025
Q2 | $886K | Sell |
2,186
-64
| -3% | -$26.8K | 0.42% | 78 |
|
|
2025
Q1 | $1.12M | Buy |
2,250
+121
| +6% | +$65.5K | 0.62% | 64 |
|
|
2024
Q4 | $1.11M | Sell |
2,129
-8
| -0.4% | -$4.4K | 0.58% | 71 |
|
|
2024
Q3 | $1.32M | Sell |
2,137
-6
| -0.3% | -$3.55K | 0.71% | 57 |
|
|
2024
Q2 | $1.19M | Sell |
2,143
-10
| -0.5% | -$5.73K | 0.7% | 60 |
|
|
2024
Q1 | $1.25M | Sell |
2,153
-11
| -0.5% | -$6.17K | 0.73% | 61 |
|
|
2023
Q4 | $1.15M | Sell |
2,164
-42
| -2% | -$20.3K | 0.74% | 62 |
|
|
2023
Q3 | $1.12M | Hold |
2,206
| – | – | 0.8% | 50 |
|
|
2023
Q2 | $1.15M | Buy |
2,206
+67
| +3% | +$36.2K | 0.77% | 50 |
|
|
2023
Q1 | $1.23M | Hold |
2,139
| – | – | 0.86% | 44 |
|
|
2022
Q4 | $1.18M | Buy |
2,139
+91
| +4% | +$48.2K | 0.84% | 44 |
|
|
2022
Q3 | $1.04M | Hold |
2,048
| – | – | 0.83% | 51 |
|
|
2022
Q2 | $1.11M | Hold |
2,048
| – | – | 0.82% | 43 |
|
|
2022
Q1 | $1.21M | Sell |
2,048
-511
| -20% | -$294K | 0.71% | 55 |
|
|
2021
Q4 | $1.71M | Sell |
2,559
-33
| -1% | -$20.6K | 0.89% | 33 |
|
|
2021
Q3 | $1.48M | Buy |
2,592
+50
| +2% | +$27.4K | 0.85% | 33 |
|
|
2021
Q2 | $1.28M | Sell |
2,542
-57
| -2% | -$26.9K | 0.73% | 48 |
|
|
2021
Q1 | $1.19M | Buy |
2,599
+250
| +11% | +$119K | 0.77% | 50 |
|
|
2020
Q4 | $1.09M | Buy |
2,349
+53
| +2% | +$24.9K | 0.79% | 44 |
|
|
2020
Q3 | $1.01M | Hold |
2,296
| – | – | 0.93% | 32 |
|
|
2020
Q2 | $832K | Sell |
2,296
-868
| -27% | -$291K | 0.92% | 33 |
|
|
2020
Q1 | $897K | Sell |
3,164
-65
| -2% | -$20.5K | 1.13% | 18 |
|
|
2019
Q4 | $1.05M | Buy |
3,229
+227
| +8% | +$68.8K | 0.87% | 28 |
|
|
2019
Q3 | $874K | Sell |
3,002
-108
| -3% | -$30.9K | 0.83% | 33 |
|
|
2019
Q2 | $913K | Buy |
3,110
+12
| +0.4% | +$3.31K | 0.88% | 25 |
|
|
2019
Q1 | $848K | Buy |
3,098
+60
| +2% | +$14.9K | 0.87% | 27 |
|
|
2018
Q4 | $680K | Buy |
+3,038
| New | +$713K | 0.84% | 32 |
|
Other funds holding TMO
Legacy Bridge's TMO Position: Q2 2026 in Review
Legacy Bridge held its Thermo Fisher Scientific (TMO) position steady in Q2 2026 at 2,115 shares worth $1.06M. The position accounts for 0.33% of the portfolio, ranked #90.
Legacy Bridge first reported a position in TMO in Q4 2018 and has held it in 31 quarters since. The position peaked at $1.71M in Q4 2021. 2,620 funds tracked by Wall St. Rank hold TMO as of Q2 2026.
- Legacy Bridge held 2,115 shares of Thermo Fisher Scientific worth $1.06M as of Q2 2026.
- Legacy Bridge left its Thermo Fisher Scientific share count unchanged in Q2 2026.
- Thermo Fisher Scientific made up 0.33% of Legacy Bridge's portfolio in Q2 2026, its #90 holding.
- Legacy Bridge first reported a position in Thermo Fisher Scientific in Q4 2018 and has held it in 31 quarters since.
- Legacy Bridge's Thermo Fisher Scientific position peaked at $1.71M in Q4 2021.
- 2,620 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.
Based on Legacy Bridge's 13F filing for Q2 2026, filed 13 Aug 2026.